Expensive drugs that cure hepatitis C are worth the cost, even at early stages of liver fibrosis
It is worthwhile to give patients expensive new drugs that can cure their hepatitis C much earlier than some insurers are now willing to pay for them, according to a UC San Francisco study that models the effects of treating ...
Nov 23, 2015
0
2